Levocetirizine Dihydrochloride 63868-0473-35
- Manufacturer
- Chain Drug Marketing Association Inc
- Dosage Form
- Tablet, Coated
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- June 24, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA210375
Active Ingredients
| Ingredient | Strength |
|---|---|
| Levocetirizine Dihydrochloride | 5 mg/1 |
Drug Class
Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Selected Package
63868-0473-35Selected1 BOTTLE in 1 CARTON (63868-473-35) / 35 TABLET, COATED in 1 BOTTLE